Suppr超能文献

[耶和华见证会成年成员使用心肺机进行的手术]

[Operations with a heart-lung machine in adult members of Jehovah's Witnesses].

作者信息

Sowade O, Warnke H, Scigalla P

机构信息

Klinik und Poliklinik für Herzchirurgie des Universitätsklinikums Charité der Humboldt-Universität zu Berlin.

出版信息

Anaesthesist. 1995 Apr;44(4):257-64. doi: 10.1007/s001010050152.

Abstract

Members of Jehovah's Witnesses refuse blood transfusions and blood products under any circumstances. Because of an improvement in blood salvage techniques in our centre, they are not excluded from open-heart surgery. In recent years recombinant human erythropoietin (rhEPO) has been applied to correct perioperative anemia in these patients. METHODS. Seventeen members of Jehovah's Witnesses who were more than 18 years of age were operated on using various blood salvage technique, e.g., haemoseparation and a high dose of Aprotinin. We present the first three patients treated with 4 x 500 U of i.v. rhEPO/kg body wt. given within 11 days preoperatively. Thirteen of the patients operated on had elevated preoperative risk factors, for instance poor left ventricle, severe aortic valve stenosis, metabolic syndrome, age older than 70 years, etc. In other centres that perform cardiac operations on members of Jehovah's Witnesses, these risk factors represent contraindications for open-heart surgery in these patients. RESULTS. Patients with rhEPO treatment showed a preoperative hematocrit increase of 7 Vol.% within 10 days and no postoperative complications. At the 6th postoperative hour the hematocrit returned to the starting values; in patients without rhEPO, however, the hematocrit generally had not increased to preoperative values even by the 8th day after operation. In 9 patients with preoperative elevated risk factors and a postoperative relative decrease in hematocrit below 33% we observed an uncomplicated postoperative period. Four patients with these risk factors, a pronounced decrease in hematocrit and blood loss postoperatively had various severe complications. CONCLUSIONS. Preoperative treatment with a high dose of rhEPO to enhance the hematocrit and maturity by precursor red blood cells in patients with a hematocrit below 45 Vol.% is a possibility to compensate for the blood loss perioperatively and to avoid complications from a decrease in oxygen transport capacity. The anaemia and high blood loss postoperatively are the main causes for a slightly elevated operation risk in members of Jehovah's Witnesses in all heart centres that perform cardiac operations on these patients. Nevertheless, Jehovah's Witnesses should be not excluded from cardiac operations, since open-heart surgery without use of homologous blood is becoming a routine procedure.

摘要

耶和华见证人的成员在任何情况下都拒绝输血和血液制品。由于我们中心血液回收技术的改进,他们并不被排除在心脏直视手术之外。近年来,重组人促红细胞生成素(rhEPO)已被用于纠正这些患者围手术期的贫血。方法:17名18岁以上的耶和华见证人成员接受了各种血液回收技术的手术,如血液分离和高剂量的抑肽酶。我们展示了前三例术前11天内静脉注射4×500 U rhEPO/kg体重治疗的患者。接受手术的13名患者术前存在高危因素,例如左心室功能差、严重主动脉瓣狭窄、代谢综合征、年龄大于70岁等。在其他为耶和华见证人成员进行心脏手术的中心,这些危险因素是这些患者心脏直视手术的禁忌证。结果:接受rhEPO治疗的患者在10天内术前血细胞比容增加了7体积%,且无术后并发症。术后第6小时血细胞比容恢复到起始值;然而,未接受rhEPO治疗的患者,即使在术后第8天血细胞比容通常也未增加到术前值。在9例术前高危因素且术后血细胞比容相对下降至低于33%的患者中,我们观察到术后过程无并发症。4例有这些危险因素、血细胞比容明显下降且术后失血的患者出现了各种严重并发症。结论:对于血细胞比容低于45体积%的患者,术前用高剂量rhEPO治疗以提高血细胞比容并使前体红细胞成熟,有可能补偿围手术期失血并避免因氧运输能力下降而引起的并发症。贫血和术后大量失血是所有为耶和华见证人成员进行心脏手术的心脏中心手术风险略有升高的主要原因。然而,不应将耶和华见证人排除在心脏手术之外,因为不使用同源血的心脏直视手术正成为常规手术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验